Subtitle: Why stable colonisation sometimes shifts into active disease
Introduction
If microbes can live quietly in the lungs for years, why do they sometimes turn aggressive?
Evolutionary biology and microbiome research show that infection often develops because of environmental pressures — not by design, but as a by-product of survival in a changing ecosystem.
1. Antibiotic Pressure
Repeated antibiotic courses kill sensitive strains and leave behind resistant survivors.
These survivors often produce thicker biofilms and inflammatory molecules, which protect them but also damage airway tissue.
Over time, this selection creates harder-to-treat, more inflammatory strains.
2. Nutrient Competition
Airways are crowded ecosystems.
When nutrients run low, microbes compete by releasing toxins, proteases, and iron-scavenging molecules.
These harm competitors — and incidentally harm the lung.
3. Biofilms and Mutation
Within biofilms, bacteria and fungi evolve quickly.
Mutations can accumulate, producing hypermutator strains that are well adapted to chronic survival but also more inflammatory.
4. Host Factors
Changes in the body — reduced immunity, steroid use, diabetes, or viral infections — relax immune control.
Organisms that were previously contained can now proliferate.
Similarly, damaged or scarred airways provide sheltered niches where microbes thrive.
5. Microbiome Collapse
The healthy lung microbiome helps regulate inflammation and suppress invaders.
When broad antibiotics or infections reduce diversity, opportunists like Pseudomonas or Aspergillus can expand unchecked.
6. Collateral Damage, Not Intent
Most microbes don’t “want” to be pathogenic — they’re simply adapting to survive.
Their survival strategies (biofilms, enzymes, toxins) cause collateral damage to airway tissue.
So, pathogenicity is often an accidental consequence of survival pressure.
7. Cycles of Stability and Flare-Ups
Chronic airway diseases often follow repeating cycles:
-
Stable colonisation – coexistence with minimal inflammation
-
Disruption – antibiotics, viral infection, or new strain
-
Flare-up – inflammation and tissue damage
-
Partial recovery – new stable community forms
Each cycle leaves the microbial ecosystem slightly altered — selecting for organisms that can survive stress and immune attack.
Evolutionary Summary
| Pressure | Effect on Microbes | Result for Host |
|---|---|---|
| Antibiotics | Resistant, stress-adapted strains | Harder-to-treat infection |
| Nutrient limitation | Toxin and enzyme producers | Tissue damage |
| Immune suppression | Less control of microbes | Opportunistic growth |
| Microbiome loss | Opportunist expansion | Reduced resilience |
| Biofilm evolution | Genetic drift, persistence | Chronic inflammation |
Key Takeaway
Microbes evolve under pressure from antibiotics, immune stress, and competition.
They don’t plan to harm the host — they adapt to survive.
Unfortunately, those same adaptations often make them more damaging and persistent.
This is why good airway care, careful antibiotic use, and microbiome-friendly approaches are essential to keep the system in balance.
👉 Read also: Colonisation vs Infection in Airways Disease
(Learn how to recognise the difference, when treatment is needed, and how to keep microbial balance.)
Share this post
Latest News posts
⭐ Recent Aspergillosis Research Updates (Week 48)
November 26, 2025
🌿 Biologics when ABPA and CPA overlap: What Patients Need to Know
November 25, 2025
🌍 Does where you live affect aspergillosis or ABPA?
November 25, 2025
🎄 Why Christmas Decorations Can Trigger Symptoms
November 25, 2025
Side effects from Biologic Medication
November 24, 2025
Could this new gene-therapy technology help aspergillosis patients?
November 24, 2025
**Adrenal Insufficiency & Steroid Tapering:
November 20, 2025
**Understanding Medicines in Rare Forms of Aspergillosis:
November 20, 2025
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- CPA
- Carers & Family
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Research
- NAC Announcements
- Professional Guidance
- Recordings
- Research
- Research Summaries
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Steroids
- Symptoms
- Travel & Insurance
- Treatment
- Vaccines
- Weekly Updates
